This is often accompanied by nausea and vomiting
These insights may help providers and patients understand why individual responses to semaglutide or tirzepatide vary substantially across populations
Materials and methods: The retrospective study analyzed brain imaging data from 127 diabetic patients
FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes
Related Reading Semaglutide Medication Medvi Semaglutide Bioverse Semaglutide Ro Semaglutide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Phase III trials (TRIUMPH 1-4) are ongoing to confirm efficacy and safety in broader populations